This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Surgery Partners | |
|---|---|
| Name | Surgery Partners |
| Type | Public |
| Industry | Healthcare |
| Founded | 2015 |
| Founder | Daniel W. Neidorff |
| Headquarters | Nashville, Tennessee |
| Key people | Harry H. Patz, Jr. |
| Revenue | US$3.4 billion (2020) |
| Employees | 11,000 (2020) |
Surgery Partners is a United States-based healthcare company that operates an integrated platform of ambulatory surgery centers, hospitals, and ancillary services. The company offers surgical, diagnostic, and therapeutic services across multiple specialties and collaborates with physician groups, hospital systems, and payers. It has pursued growth through acquisitions, joint ventures, and capital partnerships to expand its national footprint and diversify service lines.
The company formed in the mid-2010s amid consolidation trends exemplified by transactions involving HCA Healthcare, Tenet Healthcare, Community Health Systems, Universal Health Services, and private equity firms such as Blackstone Group and Kohlberg Kravis Roberts. Early expansion echoed strategies used by Surgical Care Affiliates and AmSurg Corporation during their respective growth phases. Executives with backgrounds at institutions including Hospital Corporation of America, DaVita and Stryker Corporation guided integration of ambulatory surgery centers acquired from regional physician groups and hospital systems. The company's timeline parallels regulatory and market shifts seen in the wake of legislation such as the Affordable Care Act and reimbursement changes from the Centers for Medicare & Medicaid Services. Major capital events involved investors and underwriters active in healthcare deals alongside firms like Goldman Sachs, Morgan Stanley, and Bank of America Merrill Lynch.
Operations encompass ambulatory surgical care, inpatient surgical services, anesthesia management, imaging, and ancillary diagnostics similar to services provided by Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and regional health systems such as Kaiser Permanente. Service lines span orthopedics, ophthalmology, gastroenterology, pain management, otolaryngology, and urology—specialties also emphasized by practices affiliated with Johns Hopkins Medicine, Stanford Health Care, and UCLA Health. The platform negotiates payer contracts with commercial insurers including UnitedHealth Group, Anthem, Aetna, and Cigna, and participates in CMS payment programs. Facility management models mirror partnerships between physician investors and management companies seen in relationships between physician groups and organizations like Encompass Health and Tenet Healthcare.
The company's board and executive suite include professionals with experience at corporations and institutions such as HCA Healthcare, Community Health Systems, McKinsey & Company, Bain Capital, and legal advisories like Skadden, Arps, Slate, Meagher & Flom. Capital structure has featured public equity listed on exchanges alongside debt facilities underwritten by banks similar to J.P. Morgan Chase, Wells Fargo, and Citigroup. Governance practices reference standards advocated by groups including The Conference Board and proxy advisory firms like Institutional Shareholder Services and Glass Lewis. Leadership communications and investor relations employ filings and presentations comparable to those used by Pfizer, Johnson & Johnson, and Eli Lilly and Company for market disclosures.
Revenue and earnings have tracked trends affecting peers such as Tenet Healthcare and Universal Health Services with sensitivity to surgical case volumes, reimbursement rates from Centers for Medicare & Medicaid Services, and commercial payer negotiations. Public financial reports typically highlight metrics analogous to same-facility case growth, adjusted EBITDA, and cash flow measures used by HCA Healthcare and Encompass Health. Capital allocation has balanced reinvestment, acquisitions, and debt servicing comparable to strategies adopted by large healthcare operators including Community Health Systems and companies in the S&P 500 healthcare cohort.
Growth strategy emphasized acquisitions of ambulatory surgery centers and specialty practices, joint ventures with physician groups, and platform deals similar to transactions executed by Surgical Care Affiliates and private equity-backed rollups. Strategic partnerships have involved local hospital systems, physician ownership groups, and national payers such as UnitedHealth Group and Anthem. Investment and merger activity engaged advisors and counterparties like Evercore, Lazard, and law firms involved in healthcare M&A. Key deals echoed consolidation seen in markets served by regional chains such as Community Health Systems and national chains like HCA Healthcare.
The company operates within a regulatory framework overseen by agencies including the Centers for Medicare & Medicaid Services, the Department of Justice (United States), and state health departments in jurisdictions such as California, Texas, and Florida. Legal matters have involved compliance with anti-kickback and Stark Law considerations similar to enforcement actions affecting providers in cases prosecuted by the DOJ or investigated by state attorneys general. Quality and accreditation processes involve standards from organizations like The Joint Commission and the American College of Surgeons.
Community engagement includes charitable programs, pro bono services, and grant partnerships resembling initiatives by healthcare companies and institutions such as Robert Wood Johnson Foundation, Kaiser Permanente Community Giving, and academic medical centers like University of Pennsylvania Health System. Local workforce development, collaborations with community hospitals, and support for clinical education align with community benefit practices of entities including Mayo Clinic and Cleveland Clinic.